Literature DB >> 6354776

Inhibition of glucagon secretion in the human newborn by glucose infusion.

S Grasso, F Fallucca, D Mazzone, L Giangrande, M G Romeo, G Reitano.   

Abstract

Plasma glucagon, serum insulin, and blood glucose responses during a 30-min glucose (1 g/kg body wt) or saline infusion were reported in 37 full-term and 35 preterm infants. They were studied either on the first day of life before feeding was initiated or during the first week of life. Glucose infusion promptly suppressed glucagon secretion in all infants even from the initial hours of extrauterine life. The mean maximal decrement in percentage in the full-term infants on the day of birth and older was 54 +/- 4% and 61 +/- 6%, respectively, while the maximal decrement in the preterm infants on day of birth and older was significantly lower (44 +/- 3% and 38 +/- 4%, respectively). The insulin response to glucose was variable in all infants and most of them showed a delayed rise of serum insulin. No change in plasma glucagon, blood glucose, and serum insulin was observed during and after saline infusion.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6354776     DOI: 10.2337/diab.32.6.489

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  4 in total

Review 1.  Prevention and management of neonatal hypoglycaemia.

Authors:  A Mehta
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-01       Impact factor: 5.747

Review 2.  Neonatal hypoglycemia following maternal glucose infusion prior to delivery.

Authors:  S Singhi; S Sharma
Journal:  Indian J Pediatr       Date:  1991 Jan-Feb       Impact factor: 1.967

3.  The role of pancreatic insulin secretion in neonatal glucoregulation. II. Infants with disordered blood glucose homoeostasis.

Authors:  J M Hawdon; A Aynsley-Green; K Bartlett; M P Ward Platt
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

4.  Maturation of the response of human fetal pancreatic explants to glucose.

Authors:  B E Tuch; A Jones; J R Turtle
Journal:  Diabetologia       Date:  1985-01       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.